Sign in

CIK 0001280776

  • Non-accelerated filer
  • Smaller reporting company

IMMUNIC, INC.

Sign in to watch
Ticker
IMUX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562358443
Phone
+1 332-255-9818
Business address
1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
Former names
VITAL THERAPIES INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 100,000 shares at an average $5.48 ($548,335)
  3. 4 Open-market buy Director bought 150,000 shares at an average $4.89 ($733,140)
  4. 4 Open-market buy Director bought 59,200 shares at $4.19 ($247,870)
  5. 4 Open-market buy Director bought 130,000 shares at an average $4.01 ($521,229)
  6. 4 Open-market buy Director bought 10,000 shares at $4.00 ($39,969)
  7. 4 Open-market buy Director bought 50,000 shares at $3.53 ($176,615)
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy General Counsel and Secretary bought 2,500 shares at an average $3.09 ($7,724)
  10. 4 Open-market buy Co-Chairman and CEO bought 10,000 shares at $3.10 ($30,981)
  11. 4 Open-market buy Director bought 16,000 shares at $3.00 ($48,069)
  12. 4 Open-market buy Director bought 20,000 shares at an average $3.07 ($61,319)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 16 · 313 filings